SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-343906
Filing Date
2012-08-08
Accepted
2012-08-08 15:44:02
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d350863d10q.htm 10-Q 564518
2 EX-10.1 d350863dex101.htm EX-10.1 13502
3 EX-31.1 d350863dex311.htm EX-31.1 10137
4 EX-31.2 d350863dex312.htm EX-31.2 10155
5 EX-32.1 d350863dex321.htm EX-32.1 3473
6 EX-32.2 d350863dex322.htm EX-32.2 3491
  Complete submission text file 0001193125-12-343906.txt   4030365

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bcrx-20120630.xml EX-101.INS 520237
8 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20120630.xsd EX-101.SCH 46432
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20120630_cal.xml EX-101.CAL 46122
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20120630_def.xml EX-101.DEF 101628
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20120630_lab.xml EX-101.LAB 332592
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20120630_pre.xml EX-101.PRE 225898
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 121016789
SIC: 2836 Biological Products, (No Diagnostic Substances)